Singapore markets close in 5 hours 14 minutes
Straits Times Index
3,305.86 +13.17 (+0.40%) Nikkei
38,299.71 +25.66 (+0.07%) Hang Seng
18,157.64 +394.61 (+2.22%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,447.10 -2,673.73 (-4.45%) CMC Crypto 200
1,263.79 -75.27 (-5.62%)
ABT Jan 2026 155.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
| Previous close | 1.7800 |
| Open | 1.7800 |
| Bid | 1.0600 |
| Ask | 2.2900 |
| Strike | 155.00 |
| Expiry date | 2026-01-16 |
| Day's range | 1.7800 - 1.7800 |
| Contract range | N/A |
| Volume | |
| Open interest | 16 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.